These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34228066)

  • 1. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
    Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
    JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health related adverse events of cytisine and varenicline in smokers with and without mental health disorders: Secondary analysis of a randomized controlled trial.
    Rubaiya Talukder S; Lappin J; Clare Boland V; Weaver N; McRobbie H; James Courtney R
    Addict Behav; 2024 Dec; 159():108148. PubMed ID: 39213816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytisine versus nicotine for smoking cessation.
    Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
    N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.
    Walker N; Smith B; Barnes J; Verbiest M; Parag V; Pokhrel S; Wharakura MK; Lees T; Cubillos Gutierrez H; Jones B; Bullen C
    Addiction; 2021 Oct; 116(10):2847-2858. PubMed ID: 33761149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.
    Walker N; Howe C; Bullen C; McRobbie H; Glover M; Parag V; Williman J; Veale R; Nosa V; Barnes J
    BMC Public Health; 2011 Nov; 11():880. PubMed ID: 22104038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.
    Oreskovic T; Percac-Lima S; Ashburner JM; Tiljak H; Rifel J; Klemenc Ketiš Z; Oreskovic S
    Nicotine Tob Res; 2023 Aug; 25(9):1547-1555. PubMed ID: 37291049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
    Rigotti NA; Benowitz NL; Prochaska J; Leischow S; Nides M; Blumenstein B; Clarke A; Cain D; Jacobs C
    JAMA; 2023 Jul; 330(2):152-160. PubMed ID: 37432430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline and Nicotine Replacement Therapy for Smokers Admitted to Hospitals: A Randomized Clinical Trial.
    Weeks GR; Gobarani RK; Abramson MJ; Bonevski B; Webb A; Thomas D; Paul E; Sarwar MR; Smith BJ; Perinpanathan S; Kirsa S; Parkinson J; Meanger D; Coward L; Rofe O; Lee P; van den Bosch D; George J
    JAMA Netw Open; 2024 Jun; 7(6):e2418120. PubMed ID: 38935378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
    Tindle HA; Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Yaroslavtseva T; Bendiks S; Patts G; Hahn J; So-Armah K; Stein MD; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2022 Aug; 5(8):e2225129. PubMed ID: 35930287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytisine for smoking cessation: A systematic review and meta-analysis.
    Ofori S; Lu C; Olasupo OO; Dennis BB; Fairbairn N; Devereaux PJ; Mbuagbaw L
    Drug Alcohol Depend; 2023 Oct; 251():110936. PubMed ID: 37678096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.